Liquid Biopsy in Mature B-cell Tumors
Prospective, Observational, Multi-centred, Non-interventional Research Project on Plasma Cell Free DNA Genotyping as a Tool to Inform Mature B-cell Tumor Management
Sponsor: Oncology Institute of Southern Switzerland
Listed as NCT03280394, this observational or N/A phase trial focuses on Mature B-Cell Neoplasm and remains actively recruiting participants. Sponsored by Oncology Institute of Southern Switzerland, it has been updated 15 times since 2017, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
15 versions recorded-
Sep 2024 — Present [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
Dec 2023 — Jul 2024 [monthly]
Recruiting
-
Sep 2022 — Dec 2023 [monthly]
Recruiting
-
Dec 2021 — Sep 2022 [monthly]
Recruiting
▶ Show 10 earlier versions
-
Oct 2021 — Dec 2021 [monthly]
Recruiting
-
Mar 2021 — Oct 2021 [monthly]
Recruiting
-
Jan 2021 — Mar 2021 [monthly]
Recruiting
-
Nov 2020 — Jan 2021 [monthly]
Recruiting
-
Jan 2020 — Nov 2020 [monthly]
Recruiting
-
Mar 2019 — Jan 2020 [monthly]
Recruiting
-
Jun 2018 — Mar 2019 [monthly]
Recruiting
-
May 2018 — Jun 2018 [monthly]
Recruiting
-
Apr 2018 — May 2018 [monthly]
Recruiting
Phase: NA → None
-
Oct 2017 — Apr 2018 [monthly]
Recruiting NA
First recorded
Sep 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Oncology Institute of Southern Switzerland
For direct contact, visit the study record on ClinicalTrials.gov .